This is the authors' abstract. We don't add key points for this paper.
Background Acetylsalicylic acid-associated thrombocytopenia is rare and has mainly been described in isolated case reports. We report a case of acute thrombocytopenia temporally associated with an acetylsalicylic acid-containing preparation in an elderly patient with multiple comorbidities.Case report A 71-year-old woman developed abrupt thrombocytopenia during hospitalisation, with platelet counts decreasing from 338 × 109/L to 25 × 109/L without major bleeding manifestations. Peripheral blood smear confirmed marked thrombocytopenia without platelet aggregation or schistocytes. The acetylsalicylic acid-containing preparation was discontinued, whereas Linagliptin treatment was continued. Platelet counts subsequently recovered and normalised during follow-up. Causality assessment using the Naranjo Adverse Drug Reaction Probability Scale supported a probable drug-related association.Discussion Previous reports have suggested possible immune-mediated and idiosyncratic mechanisms for acetylsalicylic acid-associated thrombocytopenia. Although alternative etiologies could not be completely excluded in the present case, the temporal relationship between drug exposure and platelet recovery after withdrawal supported a possible association. Clinicians should remain aware that acetylsalicylic acid-containing preparations may potentially contribute to severe haematologic adverse events, particularly in elderly patients with multiple comorbidities and polypharmacy.
No takes yet. Share an insight, caveat, or question.
He et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: